RA Capital Management, LLC, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), bought 7,803 shares at $19.86 ($155K) on 2016-01-15, disclosed to the SEC on 2016-01-20.
Open-market purchase of $155k ACRS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.86 | 1,800 | $36K | 23.0% |
| 2 | $19.88 | 4,200 | $83K | 53.8% |
| 3 | $19.88 | 1,803 | $36K | 23.1% |
| Total | $19.87 avg | 7,803 | $155K | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |